{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-22FL401J/e095a889-9b25-4c3e-b37e-df0fb4aeb668/PDF","dcterms:extent":"258 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-22FL401J/04c32635-6d4c-4e9f-b9e0-51bfdd54036b/TEXT","dcterms:extent":"22 KB"}],"edm:TimeSpan":{"@rdf:about":"2022-2025","edm:begin":{"@xml:lang":"en","#text":"2022"},"edm:end":{"@xml:lang":"en","#text":"2025"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:doc-22FL401J","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/URN:NBN:SI:spr-UCB4A42Q"},{"@xml:lang":"sl","#text":"Placebo"}],"dcterms:issued":"2025","dc:creator":"Karakaš, Izidora","dc:format":[{"@xml:lang":"sl","#text":"številka:4"},{"@xml:lang":"sl","#text":"str. 51-54"}],"dc:identifier":["COBISSID_HOST:248510979","ISSN:2820-5014","URN:URN:NBN:SI:doc-22FL401J"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Fakulteta za farmacijo, ŠSSFD"},"dc:subject":[{"@xml:lang":"en","#text":"advanced melanoma"},{"@xml:lang":"en","#text":"brain metastases"},{"@xml:lang":"en","#text":"immune-checkpoint"},{"@xml:lang":"en","#text":"immunotherapy"},{"@xml:lang":"sl","#text":"Imunoterapija"},{"@xml:lang":"en","#text":"inhibitors"},{"@xml:lang":"sl","#text":"Melanom"},{"@xml:lang":"sl","#text":"možganske metastaze"},{"@xml:lang":"sl","#text":"napredovali melanom"},{"@xml:lang":"sl","#text":"tarčna terapija"},{"@xml:lang":"en","#text":"targeted therapy"},{"@xml:lang":"sl","#text":"zaviralci imunskih nadzornih točk"}],"dcterms:temporal":{"@rdf:resource":"2022-2025"},"dc:title":{"@xml:lang":"sl","#text":"Sistemsko zdravljenje napredovalega melanoma| različni pristopi zdravljenja dermatoveneroloških bolezni|"},"dc:description":[{"@xml:lang":"sl","#text":"Melanoma is the most lethal form of skin cancer. In its advanced stages, the disease commonly metastasizes to the brain, substantially worsening prognosis and reducing overall survival. Immunotherapy and targeted therapies have fundamentally transformed the oncology landscape, offering significant improvements in survival outcomes and effectively delaying disease progression. In selecting the optimal therapeutic strategy, clinicians adhere to internationally established guidelines and meticulously assess a broad range of clinical and biological factors. A personalized treatment approach is essential to mitigate the risk of adverse events and to prevent the development of therapeutic resistance"},{"@xml:lang":"sl","#text":"Melanom je najsmrtonosnejša oblika kožnega raka. Pri napredovali obliki bolezni pogosto zaseva v možgane, kar dodatno poslabša prognozo in zmanjša možnost preživetja. Imunoterapija in tarčna terapija predstavljata pomemben preboj v onkološkem zdravljenju, saj bistveno podaljšata preživetje in upočasnita napredovanje bolezni. Pri izbiri optimalne terapevtske strategije zdravnik upošteva mednarodno uveljavljene smernice ter celostno presoja širok nabor kliničnih in bioloških parametrov. Personalizirana obravnava pomembno zmanjša tveganje za pojav neželenih učinkov ter za razvoj odpornosti proti tarčnim zdravilom in imunoterapiji"}],"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:doc-22FL401J","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:doc-22FL401J"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:doc-22FL401J/e095a889-9b25-4c3e-b37e-df0fb4aeb668/PDF"},"edm:rights":{"@rdf:resource":"http://rightsstatements.org/vocab/InC/1.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:dataProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:doc-22FL401J/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:doc-22FL401J"}}}}